Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Updates Guidance On Unique Device Identification Labeling For Class I Devices

Executive Summary

The US FDA’s most recent guidance revises UDI requirements for class I and unclassified medical devices the agency issued in July. Class I devices categorized as consumer health products will be exempt from some submission requirements.

You may also be interested in...



FDA Extends Manufacturers’ UDI Compliance Time Due To COVID-19

Due to the ongoing coronavirus crisis, regulators have put pushed back deadlines for meeting UDI requirements. In some instances, they will no longer require direct-mark UDI information if it can be garnered from other data on the device.

Democratic Lawmakers Want ACA Contraceptive Coverage Enforced

The Affordable Care Act requires health insurers to cover contraceptives; some lawmakers in the US House want to make sure those requirements are upheld.

FDA Warns Of Overdose Risk For ENFit Syringes

The US FDA issued a safety communication to patients and health care providers about the potential for overdose when using ENFit low dose tip syringes, and also told manufacturers to update labeling to account for the risk.

Topics

UsernamePublicRestriction

Register

MT144575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel